Kymera Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update

BROADEN2 Phase 2b trial in atopic dermatitis (AD) ongoing, with data expected by mid-2027KT-621 BREADTH Phase 2b trial in asthma ...

Zai Lab Limited (ZLAB) Q4 2025 Earnings Call Transcript

Hello, ladies and gentlemen. Thank you for standing by, and welcome to Zai Lab's Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, today's ...

BridgeBio Pharma, Inc. (BBIO) Q4 2025 Earnings Call Transcript

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsChinmay Shukla - Senior Vice President of ...

BAE Systems plc (OTC:BAESY) Q4 2025 earnings call transcript

BAE Systems plc (OTC:BAESY) Q4 2025 Earnings Call Transcript February 18, 2026 BAE Systems plc misses on earnings expectations. Reported EPS is $2.13 EPS, expectations were $2.21. Operator: Good day, ...

Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results and Provides a Corporate Update

Medicenna to present updated internal and external data sets related to bizaxofusp (MDNA55) at the 7th Annual Glioblastoma Development Summit to ...

Axon reports Q4 2025 revenue of $797 million, up 39% year over year

Fellow shareholders, Axon completed another record year in pursuit of our mission to protect life. Revenue grew 33% year over year, marking our fourth consecutive year of annual g ...

Excellence in Engineering: Supermaly Recognized as a China Leading Industrial Diesel Generator Set Supplier

WEIFANG, SHANDONG, CHINA, January 29, 2026 /EINPresswire.com/ -- The global industrial landscape relies heavily on the ...
The PIE News

Skills-focussed Indian business school set for university status

Master's Union, a Gurgaon-based institution founded in 2020 seen as an alternative to the Indian Institutes of Management, could soon become a state private university as Haryana government tightens ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2025 earnings call transcript

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2025 Earnings Call Transcript February 12, 2026 Vertex Pharmaceuticals ...
JEC

r-LightBioCom:“It’s not just about end-of-life, it’s about making sustainability intrinsic to material and product design”

The journey towards circular high-performance composites begins with one core question: why redesign an already mature class of materials? To set the scene, we asked the consortium to describe the ...

Medicenna Therapeutics Corp.: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results and Provides a Corporate Update

Medicenna to present updated internal and external data sets related to bizaxofusp (MDNA55) at the 7th Annual Glioblastoma Development Summit to be held in Boston from 17-19 February 2026 Updated ABIL ...
PharmiWeb

Prothena Reports Fourth Quarter and Full Year 2025 Financial Results, and Provides Financial Guidance and Business Highlights

Net cash used in operating and investing activities was $23.3 million and $163.7 million for the fourth quarter and full year of 2025, respectively; quarter-end cash and restricted cash position was ...